Aurisco Pharmaceutical (605116.SH) subsidiary receives drug registration certificate for Estradiol and Dydrogesterone Tablets
Aurisco Pharmaceutical (605116.SH) announced that recently, its wholly-owned subsidiary Yangzhou Aurisco Pharmaceutical Co., Ltd. received a Drug Registration Certificate for Estradiol and Dydrogesterone Tablets approved and issued by the National Medical Products Administration. The drug is a hormone replacement therapy (HRT) medication indicated for the treatment of estrogen deficiency symptoms in women who are at least 12 months postmenopausal.
Aurisco Pharmaceutical (605116.SH) announced that recently, its wholly-owned subsidiary Yangzhou Aurisco Pharmaceutical Co., Ltd. received a Drug Registration Certificate for Estradiol and Dydrogesterone Tablets approved and issued by the National Medical Products Administration. The drug is a hormone replacement therapy (HRT) medication indicated for the treatment of estrogen deficiency symptoms in women who are at least 12 months postmenopausal.
Related Articles
.png)
Industrial (601377.SH) approved to issue short-term corporate bonds of no more than RMB15 billion.

Lowe's Companies, Inc. (LOW.US) Q3 Earnings Call: Tariff Refunds "First Priority Is Giving Back to Customers," U.S. Home Improvement Market Far from Saturated with Significant Room for Share Gains

HK Stock Market Move | KEYTOP PARKING (02272) rose nearly 50% in late trading, up nearly 90% over two days; its Snail Parking Space platform has cumulative transaction value of RMB1.4 billion
Industrial (601377.SH) approved to issue short-term corporate bonds of no more than RMB15 billion.
.png)
Lowe's Companies, Inc. (LOW.US) Q3 Earnings Call: Tariff Refunds "First Priority Is Giving Back to Customers," U.S. Home Improvement Market Far from Saturated with Significant Room for Share Gains

HK Stock Market Move | KEYTOP PARKING (02272) rose nearly 50% in late trading, up nearly 90% over two days; its Snail Parking Space platform has cumulative transaction value of RMB1.4 billion






